APNHY:OTCMKTS
Aspen Pharmacare Holdings ADR
$9.22
0.00%
(0.00) 1D
Sep 2, 11:00:38 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for APNHY...
Mkt. cap
67.13B
Avg. vol.
102.00
Volume
11.00
52-wk high
$9.45
52-wk low
$5.25
Beta
0.79
Shares outstanding
446.25M
No. of employees
9K
Mkt. cap
67.13B
Avg. vol.
102.00
Volume
11.00
52-wk high
$9.45
52-wk low
$5.25
Beta
0.79
Shares outstanding
446.25M
No. of employees
9K
News stories
From web sources and news partners
Semafor
·
21 hours ago
Aspen Pharmacare sees weight-loss drugs driving earnings
GuruFocus
·
1 day ago
Aspen Pharmacare Holdings Ltd (APNHF) (FY 2026) Earnings Call Hi
Investing.com Canada
·
2 days ago
Earnings call transcript: Aspen Pharmacare lifts FY 2026 profit, guides for stronger 2027
FXLeaders
·
2 days ago
Aspen Pharmacare Share Price Falls 7% Despite Strong FY2027 Earnings Forecast
Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. The largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016, Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for five years in the European Union. Wikipedia
About Aspen Pharmacare Holdings ADR
CEOStephen Saad
Employees9.34K
Founded1850
HeadquartersDurban, KwaZulu-Natal, South Africa
SectorPharmaceutical industry
Websiteaspenpharma.com